Legislature Hearing Demanded to Ban Menthol Cigarettes in NYC

Regulations by 2FIRSTS.ai
Nov.20.2023
Legislature Hearing Demanded to Ban Menthol Cigarettes in NYC
New York City social justice and health groups demand a hearing on Intro 577, legislation to end the sale of menthol cigarettes in the city.

According to a report by Readme, a New York City advocacy group for social justice and health has demanded that the City Council hold a public hearing on Intro 577 legislation. This legislation aims to ban the sale of menthol cigarettes in the city.

 

Despite the support of half of the city council members and civil rights leaders, Intro 577 has yet to undergo a public hearing after more than a year of waiting. Council Member Lynn Schulman, chair of the Health Committee, is the initiator of this bill. Last week, Senator Gillibrand also expressed support for the federal ban on the sale of menthol cigarettes.

 

Tabitha Ellis, Chairwoman of the Advocacy Committee of the American Heart Association in New York City, has called for the removal of mint-flavored tobacco products from the market. Mint flavoring has been found to make smoking easier to start and harder to quit. Each year, without legislation to end the sale of mint-flavored cigarettes in New York City, thousands of new teenagers, predominantly from minority communities, will begin smoking and develop nicotine addiction through mint-flavored products. For decades, major tobacco companies have aggressively marketed mint-flavored tobacco products in minority communities, but we can now tackle this issue through effective legislation.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.